| Title |
Interleukin-1 blocking agents for treating COVID-19
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2022
|
| DOI | 10.1002/14651858.cd015308 |
| Pubmed ID | |
| Authors |
Mauricia Davidson, Sonia Menon, Anna Chaimani, Theodoros Evrenoglou, Lina Ghosn, Carolina Graña, Nicholas Henschke, Elise Cogo, Gemma Villanueva, Gabriel Ferrand, Carolina Riveros, Hillary Bonnet, Philipp Kapp, Conor Moran, Declan Devane, Joerg J Meerpohl, Gabriel Rada, Asbjørn Hróbjartsson, Giacomo Grasselli, David Tovey, Philippe Ravaud, Isabelle Boutron |
X Demographics
The data shown below were collected from the profiles of 54 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 6 | 11% |
| United Kingdom | 4 | 7% |
| Spain | 3 | 6% |
| Ireland | 3 | 6% |
| United States | 3 | 6% |
| South Africa | 2 | 4% |
| Australia | 2 | 4% |
| Canada | 2 | 4% |
| Denmark | 1 | 2% |
| Other | 5 | 9% |
| Unknown | 23 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 37 | 69% |
| Scientists | 10 | 19% |
| Practitioners (doctors, other healthcare professionals) | 6 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 124 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 15% |
| Student > Bachelor | 12 | 10% |
| Researcher | 10 | 8% |
| Other | 6 | 5% |
| Professor | 6 | 5% |
| Other | 19 | 15% |
| Unknown | 53 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 22% |
| Psychology | 5 | 4% |
| Nursing and Health Professions | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Economics, Econometrics and Finance | 3 | 2% |
| Other | 19 | 15% |
| Unknown | 62 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2023.
All research outputs
#724,446
of 24,820,264 outputs
Outputs from Cochrane database of systematic reviews
#1,389
of 12,983 outputs
Outputs of similar age
#18,855
of 513,084 outputs
Outputs of similar age from Cochrane database of systematic reviews
#13
of 122 outputs
Altmetric has tracked 24,820,264 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,983 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,084 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.